^{Diagnostic value of mp-US of the non-alcoholic fatty liver disease in the patients with type 2 diabetes mellitus}

Congress:

ECR 2019

Poster Number:

C-0736

Type:

Scientific Exhibit

Keywords:

Metabolic disorders, Image registration, Endocrine disorders, Imaging sequences, Diagnostic procedure, Ultrasound-Colour Doppler, Ultrasound, Elastography, Ultrasound physics, Liver, Abdomen

Authors:

O. Dynnyk, N. Marunchyn; Kyiv/UA

DOI:

10.26044/ecr2019/C-0736

DOI-Link:

https://dx.doi.org/10.26044/ecr2019/C-0736

References

1. Atlas IDF 2017. http://www.diabetesatlas.org/resources/2017-atlas.html.

2. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 2016;64:1388-1402.

3. Sethi P, Bhatia P, Gubta N et al. Liver biopsy: Small procedure with large complications. Anaesth Pain&Intensive Care 2016;20(1):111-112.

4. Hamaguchi M., Kojima T., Itoh Y. et al. The Severity of Ultrasonographic Findings in Nonalcoholic Fatty Liver Disease Re ects the Metabolic Syndrome and Visceral Fat. American J Gastroenterol 2007;102:2708–2715.

5. Chauhan A, Sultan RL, Furth L. et al. Diagnostic accuracy of hepatorenal index in the detection and grading of hepatic steatosis. J Clin ultrasound 2016;44(9):580–586.

6. Myers R.P., Pollett A., Kirsch R. et al. A Noninvasive Method for the Detection of Hepatic Steatosis Based on Transient Elastography. Disclosures Liver International 2012;32(6):902-910.

7. Sasso M., Tengher-Barna I., Ziol M. et al. Novel Controlled Attenuation Parameter (CAP™) for non-invasive assessment of steatosis using FibroScan®: validation in chronic hepatitis C. J viral hepatitis 2011;19:224-253.

8. Dynnyk O., Kobyliak N., Fedusenko A. Attenuation coefficient measurement (ACM) as a newest mode for ultrasound quantitative hepatic steatosis assessment. EPOS. Poster No.: B-1245. Congress: ECR 2017.

9. Dynnyk O., Fedusenko A., Kobyliak N. Multiparametric ultrasound (mp-US) in the chronic diffuse liver disease diagnosis. EPOS. Poster No.: C-2865. Congress: ECR 2017.

10. Berzigotti A, Piscaglia F. Ultrasound in Portal Hypertension – Part 1 and EFSUMB Recommendations for the Performance and Reporting of Ultrasound Examinations in Portal Hypertension . Ultraschall in Med 2011; 32: 548–571.

11. Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008;48:835–847.

12. Dietrich C.F., Bamber J., Berzigotti A. et al. EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version). Ultraschall in Med 2017; 38: e16–e47.

13. EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol 2015;63:237–264.

14. Petta S., Vanni E., Bugianesi E. et al. The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease. Liver international 2015;35:1566–1573. Med 2013;34(2):169-184.

15. Singh S., Allen AM, Wang Z. et al. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol 2015;13:643–654.

16. Stern C., Castera L. Noninvasive diagnosis of hepatic steatosis. Hepatol international 2017;11(1):70–78.